The U.S. government has agreed to purchase 1.4 million more courses of molnupiravir, Merck’s experimental COVID-19 antiviral drug, for roughly $1 billion, the drugmaker said Nov. 9. The deal is ...
The antiviral pill can be taken at home. More countries will have access to Merck & Co’s COVID-19 pill. The deal backed by the United Nations will allow nearly 30 drugmakers in Asia, Africa and the ...
The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...
The Medicines Patent Pool on Jan. 20 said it had signed agreements with 27 generic drugmakers to manufacture molnupiravir — Merck’s COVID-19 antiviral — to advance accessibility in 105 developing ...
The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback